NO20002754L - Engangs-sprøyte - Google Patents

Engangs-sprøyte

Info

Publication number
NO20002754L
NO20002754L NO20002754A NO20002754A NO20002754L NO 20002754 L NO20002754 L NO 20002754L NO 20002754 A NO20002754 A NO 20002754A NO 20002754 A NO20002754 A NO 20002754A NO 20002754 L NO20002754 L NO 20002754L
Authority
NO
Norway
Prior art keywords
chamber
less
protein
amino acid
stabilizer
Prior art date
Application number
NO20002754A
Other languages
English (en)
Other versions
NO324692B1 (no
NO20002754D0 (no
Inventor
Karin Limrell
Ebba Florin-Robertsson
Elvy Hoekby
Ulf Nilsson
Anders Stroem
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of NO20002754L publication Critical patent/NO20002754L/no
Publication of NO20002754D0 publication Critical patent/NO20002754D0/no
Publication of NO324692B1 publication Critical patent/NO324692B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/19—Syringes having more than one chamber, e.g. including a manifold coupling two parallelly aligned syringes through separate channels to a common discharge assembly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20002754A 1997-11-28 2000-05-29 Engangs-sproyte NO324692B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704405A SE9704405D0 (sv) 1997-11-28 1997-11-28 New syringe
PCT/SE1998/002096 WO1999027983A1 (en) 1997-11-28 1998-11-19 A ONE DOSE SYRINGE, COMPRISING A FREEZE-DRIED PROTEIN COMPOSITION, FOR ADMINISTERING OF A VOLUME LESS THAN 0.5 ml

Publications (3)

Publication Number Publication Date
NO20002754L true NO20002754L (no) 2000-05-29
NO20002754D0 NO20002754D0 (no) 2000-05-29
NO324692B1 NO324692B1 (no) 2007-12-03

Family

ID=20409182

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002754A NO324692B1 (no) 1997-11-28 2000-05-29 Engangs-sproyte

Country Status (24)

Country Link
US (1) US6152897A (no)
EP (1) EP1034007B1 (no)
JP (1) JP4564652B2 (no)
KR (1) KR100567358B1 (no)
CN (1) CN1156315C (no)
AT (1) ATE354390T1 (no)
AU (1) AU742494B2 (no)
CA (1) CA2311754C (no)
CY (1) CY1106403T1 (no)
CZ (1) CZ300255B6 (no)
DE (1) DE69837159T2 (no)
DK (1) DK1034007T3 (no)
ES (1) ES2281142T3 (no)
HK (1) HK1032920A1 (no)
HU (1) HUP0004410A3 (no)
MX (1) MXPA00005214A (no)
NO (1) NO324692B1 (no)
NZ (1) NZ505150A (no)
PL (1) PL193243B1 (no)
PT (1) PT1034007E (no)
RU (1) RU2214285C2 (no)
SE (1) SE9704405D0 (no)
SK (1) SK285668B6 (no)
WO (1) WO1999027983A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060157507A1 (en) * 2004-12-30 2006-07-20 Chang Byeong S Multi-functional container closure delivery system
US20060144869A1 (en) * 2004-12-30 2006-07-06 Chang Byeong S Container closure delivery system
US7959600B2 (en) 2004-12-30 2011-06-14 Byeong S. Chang Container closure delivery system
US8062254B2 (en) 2008-01-08 2011-11-22 MacLean, LLC Spring driven adjustable oral syringe
CN103582473B (zh) 2011-01-10 2016-11-02 拜昂·塞翁·常 紧凑药物复原装置和方法
GB2498774A (en) 2012-01-27 2013-07-31 Bruce Roser Glass-stabilised biological materials and syringe
KR102276304B1 (ko) 2013-09-27 2021-07-14 한미약품 주식회사 지속형 인간 성장 호르몬 제제
JP6785770B2 (ja) 2014-09-09 2020-11-18 チャン，ビョン，ソン 溶液送達デバイスおよび方法
EP3549946A4 (en) * 2016-11-29 2020-10-21 Spiber Inc. COMPOSITION OF PROTEIN, ITS PRODUCTION PROCESS AND PROCESS FOR IMPROVING THERMAL STABILITY
CN108498467B (zh) * 2018-05-21 2019-03-05 中山未名海济生物医药有限公司 注射用重组人生长激素无菌粉末及其制备方法
IL272145A (en) * 2020-01-20 2021-07-29 Stem Cell Medicine Ltd Cosmetic preparations with protein concentrate from a conditioned growth medium of stem cells from adipose tissue

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL86799A (en) * 1987-07-02 1993-03-15 Kabi Pharmacia Ab Method and device for injection
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
JP3108077B2 (ja) * 1989-06-08 2000-11-13 住友製薬株式会社 製剤投与器
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
US5158546A (en) * 1991-08-07 1992-10-27 Habley Medical Technology Corp. Controlled action self-mixing vial
US5281198A (en) * 1992-05-04 1994-01-25 Habley Medical Technology Corporation Pharmaceutical component-mixing delivery assembly
SE9202108D0 (sv) * 1992-07-07 1992-07-07 Kabi Pharmacia Ab Dual-chamber injection cartridge
CA2337745C (en) * 1992-07-31 2005-04-12 Genentech, Inc. Human growth hormone aqueous formulation
US5334162A (en) * 1993-03-15 1994-08-02 Eli Lilly And Company Cartridge assembly for a lyophilized compound forming a disposable portion of an injector pen and method for same
FR2752733B1 (fr) * 1996-09-05 1998-11-06 Inst Nat Sante Rech Med Dispositif permeable a base d'hydrogel contenant des cellules vivantes, et ses applications

Also Published As

Publication number Publication date
CY1106403T1 (el) 2011-10-12
CA2311754A1 (en) 1999-06-10
HUP0004410A2 (hu) 2001-04-28
PT1034007E (pt) 2007-04-30
DE69837159D1 (de) 2007-04-05
NZ505150A (en) 2002-08-28
SK285668B6 (sk) 2007-06-07
NO324692B1 (no) 2007-12-03
CZ20001948A3 (cs) 2001-04-11
RU2214285C2 (ru) 2003-10-20
DE69837159T2 (de) 2007-11-22
JP2001524360A (ja) 2001-12-04
HUP0004410A3 (en) 2003-05-28
EP1034007B1 (en) 2007-02-21
EP1034007A1 (en) 2000-09-13
US6152897A (en) 2000-11-28
KR100567358B1 (ko) 2006-04-04
JP4564652B2 (ja) 2010-10-20
CZ300255B6 (cs) 2009-04-01
MXPA00005214A (es) 2002-04-24
ATE354390T1 (de) 2007-03-15
KR20010032514A (ko) 2001-04-25
CA2311754C (en) 2007-12-18
ES2281142T3 (es) 2007-09-16
AU1356699A (en) 1999-06-16
WO1999027983A1 (en) 1999-06-10
PL340731A1 (en) 2001-02-26
PL193243B1 (pl) 2007-01-31
DK1034007T3 (da) 2007-05-21
NO20002754D0 (no) 2000-05-29
SK7202000A3 (en) 2001-05-10
AU742494B2 (en) 2002-01-03
CN1280511A (zh) 2001-01-17
HK1032920A1 (en) 2001-08-10
SE9704405D0 (sv) 1997-11-28
CN1156315C (zh) 2004-07-07

Similar Documents

Publication Publication Date Title
CY1106403T1 (el) Μεθοδος για την παραγωγη μιας συριγγας μιας δοσης, που πepιλαμβανει μια ξηρανθεισα μεσω ψυξης συνθεση πρωτεϊνης, για τη χορηγηση ενος ογκου λιγοτepου απο 0,5 ml
MY128629A (en) Stabilized interleukin 2
UA26855C2 (uk) Фармацевтичhа композиція, яка регулює гематопоез
EA199900979A1 (ru) Композиции активированного протеина
NO993709D0 (no) Stabilisert blanding omfattende fibrinogen
ES2026708T3 (es) Jeringa de dos camaras con una carga de proteina humana sensible a la actividad como principio activo.
DE69629209D1 (de) Getrocknete zubereitung von bluttfaktoren, enthaltend trehalose
NO904378D0 (no) Fremgangsmaate for fremstilling av et modifisert protein for terapeutisk anvendelse.
KR950703987A (ko) G-csf의 안정한 동결건조된 약제학적 제제(stable lyophilized pharma ceutical preparations g-csf)
CO5050325A1 (es) Composiciones que contienen acidos difosfonicos
CA2254145A1 (en) Improved process to stabilize proteins
WO1997028181A3 (en) Post-labeling stabilization of radiolabeled proteins and peptides
JPS54147916A (en) Preparation of urokinase injection
KR900015749A (ko) 인터루킨-1제형
RU2000116647A (ru) Однодозовый шприц, содержащий композицию лиофилизованного белка, для введения объема менее, чем 0,5 мл
CA2183755A1 (en) Pharmaceutical preparation containing plasminogen activators
NZ336509A (en) Freeze-dried composition of bone morphogenetic protein human MP52
KR910005886A (ko) 안정화 백혈구 인터페론
Lippton et al. Prodepin: a new product of the adrenomedullin (ADM) gene has systemic vasodilator activity
CA2395438C (en) Dry compositions containing hydrophobic amino acid
JPS63225320A (ja) 抗体を含有する安定水性組成物
PT101007A (pt) Preparado liofilizado e estavel de icrf-187 e seu uso e processo de preparacao de liofilizado de icrf-187
TH43906B (th) อินเทอร์ลูคิน 2 ที่ถูกทำให้เสถียรแล้ว
RU96109524A (ru) Композиция - лекарственная форма противоартрозного средства глюкозамина гидрохлорида для иньекций
DE60217302D1 (de) Erhaltung von körpereigenen proteinen

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees